Epoetin 2000 IU Injection is a recombinant human erythropoietin preparation used for the management of anemia caused by reduced red blood cell production. It acts by stimulating erythropoiesis in the bone marrow, leading to an increase in hemoglobin concentration and improved oxygen-carrying capacity of the blood. This formulation is commonly prescribed in anemia associated with chronic kidney disease, cancer chemotherapy, HIV therapy, and selected surgical patients.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

• Drugs for Haemolytic, Hypoplastic & Renal Anemia

Pharmacology

Epoetin 2000 IU regulates erythropoiesis by promoting the differentiation and proliferation of erythroid precursor cells. It stimulates the release of reticulocytes into the bloodstream and enhances hemoglobin synthesis. Recombinant human epoetin, available as epoetin alfa or epoetin beta, mimics endogenous erythropoietin and is effective in managing anemia related to chronic renal failure, chemotherapy in cancer patients, and zidovudine therapy in HIV-infected individuals.

Indications

Epoetin 2000 IU is indicated for the treatment of:

• Anemia associated with chronic renal failure, including patients on dialysis and those not on dialysis

• Anemia in patients with non-myeloid malignancies receiving chemotherapy

• Anemic patients (hemoglobin >10 to <13 g/dL) scheduled for elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions

• Anemia related to zidovudine therapy in HIV-infected patients

Dosage and Administration

Anemia in Chronic Renal Failure

• Adults: 50–100 IU/kg three times weekly (IV or subcutaneous)

• Pediatric patients: 50 IU/kg three times weekly

• Target hemoglobin: 11–12 g/dL

• Maintenance dose: Individualized; commonly 75 IU/kg three times weekly in dialysis patients

Anemia in Cancer Patients on Chemotherapy

• Adults: 150 IU/kg three times weekly subcutaneously or 40,000 IU weekly

• Pediatric patients: 25–300 IU/kg, 3–7 times per week

• Dose adjustments based on hematocrit and clinical response

Surgery Patients

• 300 IU/kg/day subcutaneously for 10 days before surgery, on the day of surgery, and for 4 days after surgery

• Alternatively, 600 IU/kg subcutaneously once weekly for 3 weeks prior to surgery plus one dose on the day of surgery

Zidovudine-treated HIV-infected Patients

• Adults: 100 IU/kg IV or subcutaneous three times weekly

• Pediatric patients: 50–400 IU/kg, 2–3 times weekly

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Administration Guidelines

• Do not shake the vial

• Inspect solution for particulate matter and discoloration before use

• Administer IV injection over 1–2 minutes; in dialysis patients, give after dialysis

• Subcutaneous injection should not exceed 1 ml per site

• Do not mix with other IV solutions

Drug Interactions

• Haematinics may enhance therapeutic response

• Increased heparin dose may be required in dialysis patients

Contraindications

• Uncontrolled hypertension

• Known hypersensitivity to epoetin or mammalian cell-derived products

Side Effects

• General: Headache, dizziness, fever, malaise, arthralgia

• Cardiovascular: Hypertension, palpitations

• Gastrointestinal: Nausea, vomiting, diarrhea, anorexia

• Metabolic: Occasional hyperkalemia

• Allergic reactions may occur

Precautions and Warnings

• Use cautiously in patients with controlled hypertension, ischemic vascular disease, seizure disorders, or suspected hypersensitivity

• Iron status should be evaluated before and during therapy

• Most patients require iron supplementation to ensure adequate erythropoietic response

Use in Pregnancy and Lactation

• Pregnancy Category C

• Use during pregnancy only if clearly needed

• Caution is advised when administering to nursing mothers due to unknown excretion in breast milk

Overdose

• Doses up to 1500 IU/kg have been administered without direct toxicity

• Therapy should be withheld if hemoglobin exceeds target range

• Phlebotomy may be considered if polycythemia develops

Storage Conditions

• Store at 2°C to 8°C

• Protect from light

• Do not freeze

• Avoid shaking.